Matthew G. Johnson

Statistics

Publications

Citations

3.1K

H-Index

Active since

2004

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Mayo Clinic

Children's Hospital of Orange County

Children's Hospital of Michigan

JMI Laboratories

Matthew G. Johnson is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, pharmacotherapy, and infectious diseases.

ORCID

Publications per year

2004–2023

Publications

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

Angélica Jayk Bernal, Monica Maria Gomes da Silva, Dany Badibanga Musungaie et al. · New England Journal of Medicine · 2021 · 1.9K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery

Gunjan Y. Gandhi, Gregory A. Nuttall, Martin Abel et al. · Annals of Internal Medicine · 2007 · 609 citations

Medicine, Perioperative Medicine, Surgery +17

The SNM Practice Guideline for Somatostatin Receptor Scintigraphy 2.0

Helena Balon, Tracy L. Brown, S. J. Goldsmith et al. · Journal of Nuclear Medicine Technology · 2011 · 86 citations · Full text

Medicine, Endocrinology, Nuclear Medicine +6

Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19

Matthew G. Johnson, Amy Puenpatom, Pablo Andrés Moncada et al. · Annals of Internal Medicine · 2022 · 71 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Association of Heparin-Dependent Antibodies and Adverse Outcomes in Hemodialysis Patients: A Population-Based Study

Lourdes Peña de la Vega, Randal S. Miller, Margaret M. Benda et al. · Mayo Clinic Proceedings · 2005 · 62 citations

Medicine, Hematology, Nephrology +12

1–5 of 23